Kuala Lumpur, 26 August 2019 – U Mobile, the data-centric and multiple award-winning telcos, and Centre for Biomedical Technology Integration (CBMTI), a research and development-based company set up by University of Malaya, has signed a Memorandum of Understanding to conduct 5G healthcare live trials in select hospitals.
The trials will take place starting from the fourth quarter of 2019. The partnership will see U Mobile powering CBMTI’s medical communication device called MEDCOM during the 5G live trials.
“U Mobile is committed to bring the benefits of 5G technology to Malaysians and healthcare is one of the areas that we are conducting live trials in order to reap the full benefits of 5G technology when commercial roll out takes place.”
Wong Heang Tuck, CEO of U Mobile
MEDCOM will enable long-distance management of trauma cases for general surgeons, anesthetists and specialized medical staff as it has the ability to transmit live videos and other clinical data, as well as archive and retrieve the received information for remote supervision and consultation.
With the application of MEDCOM powered by U Mobile’s 5G network, patients in remote or underserved areas will have access to quality healthcare without having to travel the distance for it.
“U Mobile’s connectivity is essential in making these trials a success as it will enable healthcare experts to send and receive medical data and large files, making remote consultation a reality, getting us closer to our goal of making quality healthcare accessible to all Malaysians.”
Director of CBMTI, Prof Dr Vickneswaran Mathaneswaran
Discussion about this post